Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity: a Prospective Randomized Open Label Clinical Trial

NCT04030546 is registered in ClinicalTrials.gov with Vilnius University as lead sponsor.

NCT NCT04030546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04030546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivabradine to Prevent Anthracycline-induced Cardiotoxicity: a Prospective Randomized Open Label Clinical Trial
Lead sponsor
Vilnius University
Phase
Phase 3
Overall status
Unknown status
Start date
June 1, 2019
Completion date
December 31, 2020
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with cancer